VTVT
Income statement / Annual
Last year (2023), vTv Therapeutics Inc.'s total revenue was $0.00,
a decrease of 100.00% from the previous year.
In 2023, vTv Therapeutics Inc.'s net income was -$20.25 M.
See vTv Therapeutics Inc.’s key income statements, including revenue, expenses, profit, and income.
Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
Operating Revenue |
$0.00
|
$2.02 M
|
$4.01 M
|
$6.41 M
|
$2.76 M
|
$12.43 M
|
$291,000.00
|
$634,000.00
|
$519,000.00
|
$1.55 M
|
Cost of Revenue |
$13.60 M |
$92,000.00 |
$89,000.00 |
$11.02 M |
$15.12 M |
$23.04 M |
$39.64 M |
$45.75 M |
$29.58 M |
$18.73 M |
Gross Profit |
-$13.60 M |
$1.93 M |
$3.92 M |
-$4.60 M |
-$12.36 M |
-$10.60 M |
-$39.35 M |
-$45.11 M |
-$29.07 M |
-$17.18 M |
Gross Profit Ratio |
0 |
0.95 |
0.98 |
-0.72 |
-4.47 |
-0.85 |
-135.22 |
-71.16 |
-56 |
-11.09 |
Research and Development
Expenses |
$13.60 M
|
$12.36 M
|
$13.32 M
|
$11.02 M
|
$15.12 M
|
$23.04 M
|
$39.64 M
|
$45.75 M
|
$29.58 M
|
$18.73 M
|
General & Administrative
Expenses |
$11.91 M
|
$12.20 M
|
$12.34 M
|
$7.25 M
|
$8.54 M
|
$9.22 M
|
$11.33 M
|
$9.91 M
|
$9.08 M
|
$11.72 M
|
Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
Selling, General &
Administrative Expenses |
$11.91 M
|
$12.20 M
|
$12.34 M
|
$7.25 M
|
$8.54 M
|
$9.22 M
|
$11.33 M
|
$9.91 M
|
$9.08 M
|
$11.72 M
|
Other Expenses |
-$13.60 M |
-$2.67 M |
$4.06 M |
-$270,000.00 |
$828,000.00 |
-$592,000.00 |
-$190,000.00 |
-$22,000.00 |
-$2.97 M |
-$1.13 M |
Operating Expenses |
$11.91 M |
$24.56 M |
$25.67 M |
$18.27 M |
$23.66 M |
$32.26 M |
$50.97 M |
$55.65 M |
$38.66 M |
$30.45 M |
Cost And Expenses |
$25.50 M |
$24.56 M |
$25.67 M |
$18.27 M |
$23.66 M |
$32.26 M |
$50.97 M |
$55.65 M |
$38.66 M |
$30.45 M |
Interest Income |
$472,000.00 |
$352,000.00 |
$1,000.00 |
$12,000.00 |
$53,000.00 |
$61,000.00 |
$117,000.00 |
$87,000.00 |
$0.00 |
$0.00 |
Interest Expense |
$13,000.00 |
$15,000.00 |
$12,000.00 |
$692,000.00 |
$1.83 M |
$3.29 M |
$3.09 M |
$398,000.00 |
$1.74 M |
$6.01 M |
Depreciation &
Amortization |
$90,000.00
|
$92,000.00
|
$89,000.00
|
$94,000.00
|
$39,000.00
|
$218,000.00
|
$197,000.00
|
$265,000.00
|
$501,000.00
|
$864,000.00
|
EBITDA |
-$25.41 M
|
-$24.77 M
|
-$17.52 M
|
-$12.02 M
|
-$19.97 M
|
-$20.14 M
|
-$50.56 M
|
-$54.69 M
|
-$38.87 M
|
-$29.23 M
|
EBITDA Ratio |
0 |
-12.32 |
-4.4 |
-1.89 |
-7.24 |
-1.64 |
-174.42 |
-86.68 |
-73.49 |
-18.82 |
Operating Income Ratio
|
0
|
-11.17
|
-5.41
|
-1.85
|
-7.56
|
-1.59
|
-174.16
|
-86.78
|
-73.49
|
-18.66
|
Total Other
Income/Expenses Net |
-$464,000.00
|
-$2.33 M
|
$4.05 M
|
-$950,000.00
|
-$946,000.00
|
-$3.82 M
|
-$3.17 M
|
-$333,000.00
|
-$2.97 M
|
-$7.20 M
|
Income Before Tax |
-$25.97 M |
-$24.87 M |
-$17.62 M |
-$12.80 M |
-$21.84 M |
-$23.65 M |
-$53.85 M |
-$55.35 M |
-$41.11 M |
-$36.10 M |
Income Before Tax Ratio
|
0
|
-12.33
|
-4.4
|
-2
|
-7.9
|
-1.9
|
-185.04
|
-87.31
|
-79.2
|
-23.31
|
Income Tax Expense |
$0.00 |
$200,000.00 |
$115,000.00 |
-$3.98 M |
$100,000.00 |
$200,000.00 |
$800,000.00 |
-$39.00 M |
-$14.11 M |
$4.88 M |
Net Income |
-$20.25 M |
-$25.07 M |
-$17.73 M |
-$8.83 M |
-$21.94 M |
-$7.91 M |
-$16.14 M |
-$16.35 M |
-$27.50 M |
-$36.10 M |
Net Income Ratio |
0 |
-12.42 |
-4.43 |
-1.38 |
-7.94 |
-0.64 |
-55.48 |
-25.79 |
-52.98 |
-23.31 |
EPS |
-9.71 |
-13.06 |
-11.32 |
-7.49 |
-28.97 |
-25.42 |
-66.62 |
-68.52 |
-132.9 |
-173.87 |
EPS Diluted |
-9.71 |
-13.06 |
-11.32 |
-7.49 |
-28.97 |
-25.42 |
-66.62 |
-68.52 |
-132.9 |
-173.87 |
Weighted Average Shares
Out |
$2.08 M
|
$1.92 M
|
$1.57 M
|
$1.18 M
|
$757,301.00
|
$311,231.00
|
$242,330.00
|
$238,638.00
|
$206,913.00
|
$207,633.00
|
Weighted Average Shares
Out Diluted |
$2.08 M
|
$1.92 M
|
$1.57 M
|
$1.18 M
|
$757,301.00
|
$311,231.00
|
$242,331.00
|
$238,638.00
|
$206,913.00
|
$207,633.00
|
Link |
|
|
|
|
|
|
|
|
|
|